Climb Bio (CLYM) Current Assets (2020 - 2026)
Climb Bio (CLYM) reported Current Assets of $186.64 million for Q2 2026, up 113.6% from $87.38 million a year earlier and up 64.6% from the prior quarter.
Powered by 
Analysis
Climb Bio (CLYM) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Climb Bio posted Current Assets of $105.85 million, down 31.7% from FY2024.
- Current Assets has a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
- By year, Current Assets came in at $154.87 million in FY2024 (+40.5%), $110.26 million in FY2023 (-18.0%), $134.39 million in FY2022 (-9.3%) and $148.25 million in FY2021 (+573.9%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets since Q3 2024.
- Year over year, Current Assets gained in four of the last eight quarters, with growth averaging 11.0%.
- The high point for year-over-year Current Assets in five years was Q4 2021 (growth of 573.9%); the low point was Q2 2025 (a decline of 61.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $113.4 million (Q1 2026), $105.85 million (Q4 2025) and $90.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Climb Bio | 894.05 Mn | 894.05 Mn | - | 186.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 186.64 Mn |
| Mar 31, 2026 | 113.40 Mn |
| Dec 31, 2025 | 105.85 Mn |
| Sep 30, 2025 | 90.96 Mn |
| Jun 30, 2025 | 87.38 Mn |
| Mar 31, 2025 | 100.28 Mn |
| Dec 31, 2024 | 154.87 Mn |
| Sep 30, 2024 | 197.61 Mn |
| Jun 30, 2024 | 226.00 Mn |
| Mar 31, 2024 | 109.22 Mn |
| Dec 31, 2023 | 110.26 Mn |
| Sep 30, 2023 | 112.43 Mn |
| Jun 30, 2023 | 114.24 Mn |
| Mar 31, 2023 | 120.17 Mn |
| Dec 31, 2022 | 134.39 Mn |
| Sep 30, 2022 | 133.17 Mn |
| Jun 30, 2022 | 133.08 Mn |
| Mar 31, 2022 | 133.28 Mn |
| Dec 31, 2021 | 148.25 Mn |
| Sep 30, 2021 | 158.63 Mn |
API Access
Climb Bio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CLYM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CLYM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CLYM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();